Market Cap 1.47B
Revenue (ttm) 203.07M
Net Income (ttm) -54.84M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -27.01%
Debt to Equity Ratio -11.33
Volume 1,778,900
Avg Vol 2,165,648
Day's Range N/A - N/A
Shares Out 161.48M
Stochastic %K 82%
Beta 0.39
Analysts Strong Sell
Price Target $9.00

Company Profile

Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. The company offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the...

Industry: Biotechnology
Sector: Healthcare
Phone: 844 445 5704
Address:
1375 West Fulton Street, Suite 1300, Chicago, United States
dave2ta
dave2ta Oct. 25 at 3:17 PM
$XERS Interesting Article: https://finance.yahoo.com/news/looking-top-momentum-pick-why-160004828.html
1 · Reply
BuyThisOne
BuyThisOne Oct. 25 at 1:06 PM
$XERS I try to tell people how lucky I am in life and I am not sure they really believe me. I have had this surreal journey through life that few could even come close to imagining not being there for every moment of it. I have hiked 34 miles in the smokies in a day with 13k ft of elevation climb and was greeted with a huge meteor fireball in the clearing of the trail above me with 30 minutes to go. It didn't seem real. Just got back from Cali where I was able to hike among the giant sequoias in at least 14 inches of snow, breaking the fresh snow as the first people out there that day. If you know how satisfying that is you will know what I am talking about. In San Diego we hit the tail end of the 250 yr celebration of the Marine Corp and got to see a fighter jet doing some crazy maneuvers next to the highway. Just surreal. When I stumbled on this company in 2020 or so I immediately knew it was something special. The tech, the team, Gvoke, all of it. Oh the places we will go. Love you all
1 · Reply
gimoozaabi
gimoozaabi Oct. 25 at 2:17 AM
$XERS daily chart… *RSI - Strong Momentum *CCI - Strong Bullish Momentum *MACD - Clear Bullish Crossover and Strong Upward Trend *ADX - Strong Trend *OBV - Buying volume dominates *MFI - Approaching Overbought *Chaikin - Short-term Distribution *Order Flow - The stock is being aggressively accumulated by large players (+$1.42M net for Large trades).
0 · Reply
gimoozaabi
gimoozaabi Oct. 24 at 8:06 PM
0 · Reply
BillionerOfKing
BillionerOfKing Oct. 24 at 4:48 PM
$XERS Current Stock Price: $9.31 Contracts to trade: $10 XERS Nov 21 2025 Call Entry: $0.55 Exit: $0.84 ROI: 53% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
PJACOB01
PJACOB01 Oct. 24 at 4:38 PM
$XERS We should that the previous CEO for setting us on this course. I think that 40$ is coming within the next 2 years!
3 · Reply
Rescueoncredit
Rescueoncredit Oct. 24 at 4:34 PM
$ESPR $XERS was an halt year ago at the same market Capitalization like esperion. The difference is the stock price will hit soon $10 because the management is not so corrupt like esperions management.
2 · Reply
joeykool
joeykool Oct. 24 at 4:33 PM
$XERS my Halloween costume this year, I'm told is not much of a departure from the normal me...
1 · Reply
dave2ta
dave2ta Oct. 24 at 4:31 PM
$XERS It's Music Friday!!! With $XERS going through the roof, let's celebrate... This is the first song on my newest Album, "Finding Life"... Here We Go... https://soundcloud.com/daveevanssolo/did-you-hear-me?in=daveevanssolo/sets/finding-life&si=7b7510d57da7471fa93107ed77042682&utm_source=clipboard&utm_medium=text&utm_campaign=social_sharing
2 · Reply
Alon_R
Alon_R Oct. 24 at 4:23 PM
$XERS "Food for thought" During 2024, we witnessed ADMA’s MC surge to ~ $4.7B, supported by $420M in annual revenue, but just 51.5% gross margins(~ 40% less than Xeris). MC of $4.7B would translate to roughly $30 PS for XERIS ! Keep in mind, however, that the overall numbers of Xeris 2026 are very likely to be better than of Adma's in 2024. Therefore we can not exclude surge to ~ 30$ per share along 2026, before further growth. Objectively speaking(to be honest), keep in mind also, that forward-looking wise, XERIS revenue growth are better, gross margins are way better, shares outstanding count also far better and the pipeline of XERIS with XP-8121 ahead is seems better also. Just some food for thought to reflect why Xeris is possible to surge to ~ 30$ along 2026, while it has the legs to reach possibly 130$ per share 4-5 years afterwards. -> and to be clear, this takes nothing away from ADMA, which remains a strong and well-executed bio company in its own right.
0 · Reply
Latest News on XERS
Xeris In Recorlev-Fuelled Growth: Why I Choose To Buy

Sep 5, 2025, 10:03 AM EDT - 7 weeks ago

Xeris In Recorlev-Fuelled Growth: Why I Choose To Buy


Xeris Announces Details for Analyst & Investor Day

May 20, 2025, 7:30 AM EDT - 5 months ago

Xeris Announces Details for Analyst & Investor Day


Xeris Biopharma Holdings: Looking For More Growth In Q1 Earnings

May 7, 2025, 11:51 AM EDT - 6 months ago

Xeris Biopharma Holdings: Looking For More Growth In Q1 Earnings


Xeris Announces Changes to Its Board of Directors

Mar 28, 2025, 8:00 AM EDT - 7 months ago

Xeris Announces Changes to Its Board of Directors


Xeris Appoints Anh Nguyen, MD, MBA as Chief Medical Officer

Feb 24, 2025, 8:00 AM EST - 8 months ago

Xeris Appoints Anh Nguyen, MD, MBA as Chief Medical Officer


Xeris to Participate in Upcoming Investor Conferences

Feb 5, 2025, 8:00 AM EST - 9 months ago

Xeris to Participate in Upcoming Investor Conferences


Xeris Expects to Exceed Full-Year 2024 Financial Guidance

Jan 10, 2025, 7:00 AM EST - 10 months ago

Xeris Expects to Exceed Full-Year 2024 Financial Guidance


Xeris Biopharma Reports Third Quarter 2024 Financial Results

Nov 8, 2024, 7:00 AM EST - 1 year ago

Xeris Biopharma Reports Third Quarter 2024 Financial Results


Xeris Biopharma: Time For A Reassessment

Oct 9, 2024, 11:33 AM EDT - 1 year ago

Xeris Biopharma: Time For A Reassessment


Xeris Biopharma Announces CEO Succession Plan

Jul 8, 2024, 7:00 AM EDT - 1 year ago

Xeris Biopharma Announces CEO Succession Plan


Xeris Biopharma: Checking-In On One Of My 'Top Ideas'

Mar 30, 2024, 1:28 AM EDT - 1 year ago

Xeris Biopharma: Checking-In On One Of My 'Top Ideas'


Xeris Biopharma (XERS) Q4 2023 Earnings Call Transcript

Mar 6, 2024, 12:43 PM EST - 1 year ago

Xeris Biopharma (XERS) Q4 2023 Earnings Call Transcript


dave2ta
dave2ta Oct. 25 at 3:17 PM
$XERS Interesting Article: https://finance.yahoo.com/news/looking-top-momentum-pick-why-160004828.html
1 · Reply
BuyThisOne
BuyThisOne Oct. 25 at 1:06 PM
$XERS I try to tell people how lucky I am in life and I am not sure they really believe me. I have had this surreal journey through life that few could even come close to imagining not being there for every moment of it. I have hiked 34 miles in the smokies in a day with 13k ft of elevation climb and was greeted with a huge meteor fireball in the clearing of the trail above me with 30 minutes to go. It didn't seem real. Just got back from Cali where I was able to hike among the giant sequoias in at least 14 inches of snow, breaking the fresh snow as the first people out there that day. If you know how satisfying that is you will know what I am talking about. In San Diego we hit the tail end of the 250 yr celebration of the Marine Corp and got to see a fighter jet doing some crazy maneuvers next to the highway. Just surreal. When I stumbled on this company in 2020 or so I immediately knew it was something special. The tech, the team, Gvoke, all of it. Oh the places we will go. Love you all
1 · Reply
gimoozaabi
gimoozaabi Oct. 25 at 2:17 AM
$XERS daily chart… *RSI - Strong Momentum *CCI - Strong Bullish Momentum *MACD - Clear Bullish Crossover and Strong Upward Trend *ADX - Strong Trend *OBV - Buying volume dominates *MFI - Approaching Overbought *Chaikin - Short-term Distribution *Order Flow - The stock is being aggressively accumulated by large players (+$1.42M net for Large trades).
0 · Reply
gimoozaabi
gimoozaabi Oct. 24 at 8:06 PM
0 · Reply
BillionerOfKing
BillionerOfKing Oct. 24 at 4:48 PM
$XERS Current Stock Price: $9.31 Contracts to trade: $10 XERS Nov 21 2025 Call Entry: $0.55 Exit: $0.84 ROI: 53% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
PJACOB01
PJACOB01 Oct. 24 at 4:38 PM
$XERS We should that the previous CEO for setting us on this course. I think that 40$ is coming within the next 2 years!
3 · Reply
Rescueoncredit
Rescueoncredit Oct. 24 at 4:34 PM
$ESPR $XERS was an halt year ago at the same market Capitalization like esperion. The difference is the stock price will hit soon $10 because the management is not so corrupt like esperions management.
2 · Reply
joeykool
joeykool Oct. 24 at 4:33 PM
$XERS my Halloween costume this year, I'm told is not much of a departure from the normal me...
1 · Reply
dave2ta
dave2ta Oct. 24 at 4:31 PM
$XERS It's Music Friday!!! With $XERS going through the roof, let's celebrate... This is the first song on my newest Album, "Finding Life"... Here We Go... https://soundcloud.com/daveevanssolo/did-you-hear-me?in=daveevanssolo/sets/finding-life&si=7b7510d57da7471fa93107ed77042682&utm_source=clipboard&utm_medium=text&utm_campaign=social_sharing
2 · Reply
Alon_R
Alon_R Oct. 24 at 4:23 PM
$XERS "Food for thought" During 2024, we witnessed ADMA’s MC surge to ~ $4.7B, supported by $420M in annual revenue, but just 51.5% gross margins(~ 40% less than Xeris). MC of $4.7B would translate to roughly $30 PS for XERIS ! Keep in mind, however, that the overall numbers of Xeris 2026 are very likely to be better than of Adma's in 2024. Therefore we can not exclude surge to ~ 30$ per share along 2026, before further growth. Objectively speaking(to be honest), keep in mind also, that forward-looking wise, XERIS revenue growth are better, gross margins are way better, shares outstanding count also far better and the pipeline of XERIS with XP-8121 ahead is seems better also. Just some food for thought to reflect why Xeris is possible to surge to ~ 30$ along 2026, while it has the legs to reach possibly 130$ per share 4-5 years afterwards. -> and to be clear, this takes nothing away from ADMA, which remains a strong and well-executed bio company in its own right.
0 · Reply
Northwoodspeculator
Northwoodspeculator Oct. 24 at 4:13 PM
$XERS seems to me that based only on charts here, that if this takes out 12 then room to run to 18 !
0 · Reply
Bullisch_150
Bullisch_150 Oct. 24 at 3:49 PM
$XERS you are hold= you are riche-> it is a Argenx stock in wording
0 · Reply
StoicStocks
StoicStocks Oct. 24 at 3:45 PM
$XERS Nice run leading into earnings. EPS expected to be $0.01. I think we beat that! hello double digits
0 · Reply
Bullisch_150
Bullisch_150 Oct. 24 at 3:44 PM
$XERS I think we're heading towards 9.60-9.70 today
0 · Reply
TheCatInTheHat1
TheCatInTheHat1 Oct. 24 at 3:44 PM
$XERS Who's ready for a God candle?
0 · Reply
Bullisch_150
Bullisch_150 Oct. 24 at 3:43 PM
$XERS Of course, they're doing a small phase 3 project, and they're easily finding patients, so it will cost considerably less. So, of course, it would be a good choice to do this independently. The leaders must know exactly what they're doing; it's fantastic how they approach everything with practical sales.
0 · Reply
Bullisch_150
Bullisch_150 Oct. 24 at 3:34 PM
$XERS Hi Massesap, A deal is better because they usually get a substantial upfront payment, allowing them to finance new discoveries. Phase 3 also costs a lot of money, so a partner is better. Finally, large companies have sales teams that know exactly how to market this. Although Xeris knows this about sales as well, they're doing incredibly well on their own. Finally, extra cash is always a good thing; they might be able to get 50 million to several hundred million upfront.
2 · Reply
Maissessap
Maissessap Oct. 24 at 3:30 PM
$XERS No deal for XP-8121, always better alone.
1 · Reply
Bullisch_150
Bullisch_150 Oct. 24 at 3:25 PM
$XERS Yes, product 4 is on the market: GVOKE VialDX, which may also generate significant revenue now. Major deal on the horizon for XP8121 for phase 3. Further sales growth, Xeris will become a real moneymaker and a very large biotech company, unless there's a major buyout, which I still expect every day.
0 · Reply
Bullisch_150
Bullisch_150 Oct. 24 at 3:15 PM
$XERS mega deal is coming for 8121 fase 3
1 · Reply
Aptos2024
Aptos2024 Oct. 24 at 3:12 PM
$XERS deja vu ... will it (again) finish the day around 9.15?
0 · Reply
Ithaca2018
Ithaca2018 Oct. 24 at 3:10 PM
$XERS Princess! Here comes a new 52 week high!
0 · Reply